SNORA47 and breast carcinoma: To examine the way SNORA47 influences the stemness phenotype and drug responsiveness of breast cancer cells, we transfected SNORA47 and anti-SNORA47 ASOs into MCF-7 and T47D cells and used qRT-PCR to verify changes in SNORA47 expression (Fig. S2A, B).